World APS Day: Shining a Light on a Silent but Life-Threatening Autoimmune Disorder
The APS Foundation of America has shared an important update on their official X page in recognition of World APS Day. The post emphasizes the urgent need to raise awareness about Antiphospholipid Syndrome (APS)—an incurable, life-threatening autoimmune disorder that increases the risk of dangerous blood clots.
“Today is World APS Day, the global awareness campaign to raise awareness of Antiphospholipid Syndrome and its impact on our lives.
APS is an incurable, life-threatening autoimmune condition that causes the blood to clot.”
What is APS?
APS occurs when the immune system mistakenly produces antibodies that target phospholipids—critical components of cell membranes—leading to an increased risk of:
- Deep vein thrombosis (DVT)
- Pulmonary embolism
- Stroke
- Recurrent miscarriage
- Catastrophic multiorgan thrombosis in severe cases
Despite its profound clinical impact, APS remains underdiagnosed and misunderstood.
Hemostasis Today proudly joins the global movement to raise awareness, promote early diagnosis, and support ongoing research into this devastating condition. As we commemorate World APS Day, we stand with patients, families, and advocates in calling for increased education, improved testing, and more targeted therapies.
Let today be a reminder: Clots can kill, but knowledge can save lives.
Follow us on Hemostasis Today for expert insights, clinical updates, and patient stories throughout APS Awareness Month.
-
Nov 4, 2025, 09:26Courtney Lawrence: One of Our Most Popular American Red Cross SUCCESS Talks is Just Around the Corner!
-
Nov 4, 2025, 09:21New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
-
Nov 4, 2025, 09:20Yazan Abou Ismail to Present Insights on AI Models in TTP at 67th ASH Annual Meeting
-
Nov 4, 2025, 09:17David Calvet Canut on Takeda's HyHub: A Shift Toward Patient-Centered Biologics
-
Nov 4, 2025, 09:16Samantha Nelson Encourages You to Share Your Experience on World Thrombosis Day
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!